Genprex Inc GNPX:NASDAQ

RT Quote | NASDAQ | USD
Last | 10/19/21 EDT
2.36quote price arrow up+0.06 (+2.61%)
Volume
233,208
52 week range
2.24 - 7.72
Loading...
  • Open2.30
  • Day High2.39
  • Day Low2.28
  • Prev Close2.36
  • 52 Week High7.72
  • 52 Week High Date02/08/21
  • 52 Week Low2.24
  • 52 Week Low Date08/16/21

Key Stats

  • Market Cap112.17M
  • Shares Out47.53M
  • 10 Day Average Volume0.28M
  • Dividend-
  • Dividend Yield-
  • Beta-0.76
  • YTD % Change-43.13

KEY STATS

  • Open2.30
  • Day High2.39
  • Day Low2.28
  • Prev Close2.36
  • 52 Week High7.72
  • 52 Week High Date02/08/21
  • 52 Week Low2.24
  • 52 Week Low Date08/16/21
  • Market Cap112.17M
  • Shares Out47.53M
  • 10 Day Average Volume0.28M
  • Dividend-
  • Dividend Yield-
  • Beta-0.76
  • YTD % Change-43.13

RATIOS/PROFITABILITY

  • EPS (TTM)-0.43
  • P/E (TTM)-5.49
  • Fwd P/E (NTM)-4.82
  • EBITDA (TTM)-18.465M
  • ROE (TTM)-51.19%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/14/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Genprex Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Genprex, Inc. is a clinical-stage gene therapy company focused on developing treatments for cancer and diabetes. The Company's lead cancer drug candidate, REQORSA Immunogene therapy drug (also referred to as GPX-001), is being developed to treat non-small cell lung cancer (NSCLC). The active agent in REQORSA is a TUSC2 gene expressing plasmid that is encapsulated in a DOTAP cholesterol nanoparticle. TUSC2 is a tumor suppressor gene which has both tumor killing (via apoptosis)...
J. Rodney Varner
Chairman
Michael Redman
Chief Operating Officer
Ryan Confer
Chief Financial Officer
Hemant Kumar Ph.D.
Chief Technology Officer
Catherine Vaczy Esq.
Executive Vice President
Address
1601 Trinity St Bldg B
Austin, TX
78712-1765
United States

Top Peers

SYMBOLLASTCHG%CHG
HEPA
Hepion Pharmaceuticals Inc
1.54+0.01+0.65%
LTRN
Lantern Pharma Inc.
10.24+0.86+9.17%
BCLI
Brainstorm Cell Therapeutics Inc
3.14+0.04+1.29%
AGTC
Applied Genetic Technologies Corp
2.68+0.05+1.90%
IFRX
Inflarx NV
2.77+0.35+14.46%